Supernus Offers Business Update: Reaffirms Does Not Need Added Capital, Will 'Explore a Broad Range of Strategic Opportunities'

By: via Benzinga
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) is providing the following business update in light of recent investor filings with the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.